SUMMARY To assess the sensitivity of Gardnerella vaginalis to the complement mediated bactericidal activity of serum, six laboratory strains were incubated with normal human serum and two strains freshly isolated from women with non-specific vaginitis (NSV) were each incubated with homologous patient serum. There was no significant difference between the number of organisms recovered from unheated or heat inactivated serum after incubation at 37°C for one hour with any of the strains tested. A suspension of G vaginalis incubated at 37°C for one hour in heat inactivated homologous mouse antiserum with unheated normal human serum as a source of complement did not show any less viability than the control mixture using heat inactivated human serum. In contrast, a serum resistant strain of Neisseria gonorrhoeae incubated in heat inactivated homologous mouse antiserum with unheated normal human serum showed noticeably less viability than the control. G vaginalis therefore seems to be resistant to the bactericidal activity of both normal and immune serum.
Introduction
In 1955 Gardner and Dukes' reported isolating a bacterium now classified as Gardnerella vaginalis2 from 92% of women suffering from non-specific vaginitis (NSV), a condition characterised by the presence of a foul smelling vaginal discharge, an elevated vaginal pH value (>5 0), and the presence of clue cells, which are epithelial cells covered with coccobacilli. Gardner and Dukes' thought that the micro-organism they had described was the causative agent of NSV as they failed to isolate it from women not suffering from this condition. Subsequent reports that G vaginalis may be isolated from women without NSV,3-6 however, together with the observation that there is an increase in the anaerobic vaginal flora of women with NSV,67 cast doubts on the aetiological role of G vaginalis in this disease.
Though the role of G vaginalis in the pathogenesis ofNSV is not clear, there is increasing evidence that it may be a cause ofextravaginal infection. In 1971 Platt presented evidence of two cases of neonatal infection due to G vaginalis.8 The bacterium was isolated from lesions on the scalp of one child and was recovered 380 from the blood of the other child who died within six hours. When reviewing other cases of neonatal infection, Platt reported that G vaginalis had been isolated from maternal and cord blood, as well as from maternal vaginal specimens, though some isolates were from patients undergoing abortion where uterine trauma may have accounted for the organism entering the vascular system. We obtained blood samples from three volunteers on the staff of the Clinical Research Centre (CRC) and from two patients diagnosed as having NSV. The collection ofblood samples was approved by the ethics committee. Each sample was allowed to clot at room temperature for 30 minutes then kept at 4°C for another 30 minutes, after which the serum was separated by centrifugation and stored in small aliquots at-70°C. Each vial was thawed once, and any serum remaining after the experiment was discarded. Assays of haemolytic complement activity (performed by the division of immunological medicine, CRC) showed that all serum samples had normal levels of activity.
MOUSE ANTISERA Antisera to G vaginalis (strain 6376) and to Ngonorrhoeae (strain 203H) were prepared in mice using the method described by Wang et al, '9 except that the G vaginalis organisms were not treated with formalin. To prepare antigens, G vaginalis was grown for 48 hours as described above, after which the growth was removed from the agar surface using a bacteriological loop and suspended in sterile phosphate buffered saline (PBS) at a concentration of 1 x 105 colony forming units (cfu)/ml. Gonococci were grown overnight as described above, harvested into sterile PBS at a concentration of 2 x 107 cfu/ml, and treated with formalin.'9 Mice were inoculated intravenously with 0-2 ml ofeach bacterial suspension, and the inoculation was boosted seven days later using freshly prepared suspensions. Three days after that the mice were exsanguinated by bleeding from the axilla. We tested the serum samples for antibodies to G vaginalis and N gonorrhoeae by a microimmunofluorescence technique,'9 modified by not formalising the G vaginalis antigens. In brief, the bacteria were suspended in PBS at a concentration of 1 x 108 cfu/ml and mixed with an equal volume of 7% (w/v) yolk sac. Antigen dots were applied, using a mapping pen, to the wells of slides coated with Klingerflon spray (Marshall-Howlett, Kent). The antigen dots were air dried, fixed with acetone, and overlayed with serial dilutions of mouse antiserum. After incubation at 37°C in a moist chamber for one hour, the slides were washed in PBS and overlayed with rabbit anti-mouse immunoglobulin (Miles) conjugated with fluorescein. The slides were incubated as above for one hour, washed in PBS, dried in air, and examined under an epifluorescence microscope. The antibody titre was recorded as the highest dilution of serum at which the bacteria fluoresced.
BACTERICIDAL ASSAY Bacteria were grown as described above and suspended in sterile PBS. Clumps of bacteria were broken up using a needle and syringe, and the numbers of viable organisms were assessed by titration. To estimate the effect of human serum on bacterial survival, 20 ,ul of each suspension was mixed with 180,ul ofunheated or heat inactivated (at 56°C for 30 minutes) undiluted human serum and incubated at 37°C for one hour. The mixtures were then diluted tenfold in PBS, and 10, ul of each dilution was put on to the appropriate solid medium for the number of viable organisms to be counted. The susceptibility of the bacteria to the bactericidal activity ofserum was assessed by comparing the numbers of organisms surviving in unheated and heat inactivated homologous serum. In two experiments designed to study the susceptibility or resistance of G vaginalis andNgonorrhoeae to killing by specific antibody and complement, the above procedure was modified by replacing the 180 ,ul of normal human serum with a mixture of equal volumes (90,ul) of heat inactivated specific mouse antiserum and either unheated or heat inactivated human serum.
Results

SURVIVAL OF G VAGINALIS IN HUMAN SERUM
To assess the susceptibility or resistance of G (table I) but which exhibited a pronounced decrease in viability in the presence of specific antibody and complement. The reduction in the number of viable organisms, as judged by colony counts, was due to killing of the organisms and not to clumping, as the latter was not seen on Gram staining. The loss of viability of the gonococcus was only seen with the homologous, but not the heterologous antiserum, which indicated that this was a specific reaction. This specificity was further confirmed by the observation that the anti-gonococcal antiserum had no effect on the viability of the G vaginalis.
G vaginalis and Npharyngis behaved in the same way as described previously when the above experiments were undertaken using guinea pig serum diluted 1:10 as the source of complement in place of human serum.
Discussion
The results presented here show that G vaginalis is resistant to the bactericidal activity ofboth normal and immune serum. 
